Hyperglycemia rather than insulin resistance is related to reduced coronary flow reserve in NIDDM

Diabetes

Volumn 47, Issue 1, 1998, Pages 119-124

  Yokoyama, Ikuo ^a   Ohtake, Tohru ^a   Momomura, Shin Ichi ^a   Yonekura, Katsunori ^a   Woo Soo, Shin ^a   Nishikawa, Junichi ^a   Sasaki, Yasuhito ^a   Omata, Masao ^a  

^a UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; DIPYRIDAMOLE; HEMOGLOBIN A1C; INSULIN; NITROGEN 13;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; ELECTROCARDIOGRAM; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERGLYCEMIA; INSULIN RESISTANCE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL;

EID: 0031985551     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diab.47.1.119     Document Type: Article

References (48)

1. Nitenberg A, Valensi P, Sachs R, Dalim M, Aptecar E, Attali JH: Impairment of coronary vascular reserve and Ach-induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal ventricular systolic function. Diabetes 32:1017-1023, 1993
2. Nahser PJ Jr, Brown RE, Oskarsson H, Winnifold MD, Rossen JD: Maximal coronary flow reserve and metabolic coronary vasodilation in patients with diabetes mellitus. Circulation 91:635-640, 1995
3. Gould KL, Lipscomb K: Effects of coronary stenoses on coronary flow reserve and resistance. Am J Cardiol 34:48-54, 1974
4. Mintz GS, Painter JA, Pichard AD, Kent KM, Satler LF, Popma JJ, Chuang YC, Bucher TA, Sokolowicz LE, Leon MB: Atherosclerosis in angiographically normal coronary artery reference segments: an intravascular ultrasound study with clinical correlations. J Am Coll Cardiol 25:1479-1485, 1995
5. Kim JA, Berliner JA, Natarajan JL; Evidence that glucose increases monocyte binding to human aortic endothelial cells. Diabetes 43:1103-1107, 1994
6. Folsom AR, Eckfeldt JH, Weitzman S, Ma J, Chambless LE, Barnes RW, Cram KB: Relation of carotid artery wall thickness to diabetes mellitus, fasting glucose and insulin, body size, and physical activity: Atherosclerosis Risk in Communities (ARIC) Study Investigators. Stroke 25:66-73, 1994
7. Van Hoeven KH, Factor SM: A comparison of the pathological spectrum of hypertensive, diabetic, and hypertensive-diabetic heart disease. Circulation 82:848-855, 1990
8. Yegin A, Ozbn T, Yegin H: Glycation of lipoprotein and accelerated atherosclerosis in non-insulin-dependent diabetes mellitus. Int J Clin Lab Res 25:157-161, 1995
9. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR: Diabetes, blood lipids, and the role of obesity in coronary heart disease risk for women: the Framingham study. Ann Intern Med 87:393-397, 1977
10. Laakso M: Glycemic control and the risk for coronary heart disease in patients with non-insulin-dependent diabetes mellitus. Ann Intern Med 124:127-130, 1996
11. DeFronzo RA: Insulin resistance, hyperinsulinemia, and coronary artery disease: a complex metabolic web. Coron Artery Dis 3:11-25, 1992
12. Syvanne M, Kahri J, Virtanen KS, Taskinen MR: HDLs containing apolipopro teins A-I, A-II (LpA-I:A-II) as markers of coronary artery disease in men with non-insulin-dependent diabetes mellitus. Cieculation 92:364-370, 1995
13. 13N-ammonia myocardial imaging at rest and with exercise in normal volunteers. Circulation 80:1328-1337, 1989
14. 13N-ammonia and reoriented dynamic positron emission tomography. Circulation 86:1004-1017, 1992
15. Van Hoeven KH, Factor SM: Diabetic heart disease: the clinical and pathological spectrum. I and II. Clin Cardiol 12:600-604; 667-671, 1989
16. Garcia MJ, McNamara PM, Gordon T, Kannel WB: Morbidity and mortality in diabetics in the Framingham population: sixteen year follow-up study. Diabetes 23:105-111, 1974
17. Kannel WB, McGee DL Diabetes and cardiovascular disease: the Framingham study. JAMA 241:2035-2038, 1979
18. Panzram G: Mortality and survival in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 30:123-131, 1987
19. Fastor SM, Segal BH, van Hoeven KH: Diabetes and coronary artery disease. Coron Artery Dis 3:4-10, 1992
20. Durante W, Sunahara FA, San AK Effect of diabetes on metabolic coronary dilatation in the rat. Cardiovasc Res 23:40-45, 1989
21. Lee JC, Downing SE: Coronary dynamics and myocardial metabolism in the diabetic newborn lamb. Am J Physiol 237:H118-H124, 1979
22. 2 in experimental diabetes. Am J Physiol 243:H252-H258, 1982
23. Dean JD, Jones CJ, Huchison SJ, Peters JR, Henderson AH: Hyperinsulinaemia and microvascular angina ("Syndrome X"). Lancet 337:456-457, 1991
24. Chauhan A, Foote J, Petch M, Schofleld P: Hyperinsulinemia, coronary artery disease and syndrome X. J Am Coll Cardiol 23:364-368, 1994
25. Kunjatjoor VV, Wilson DL, LeBoeuf RC: Increased atherosclerosis in streptozotocin-induced diabetic mice. J Clin Invest 97:1767-1773, 1996
26. Yamazaki Y, Kawamori R, Matsushima H, Nishizawa H, Kodama M, Kubota M, Kajimoto Y, Kodama T: Asymptomatic hyperglycemia is associated with increased intimal plus medial thickness of the carotid artery. Diabetologia 38:585-591, 1995
27. The Diabetes Control and Complications Trial Research Group: The effect of intensive treatment of run he tes on the development and progression of longterm complications in insulin dependent diabetes mellitus. N Engl J Med 329:977-986, 1993
28. Davidoff F, Case K, Fried P: Evidence-based medicine: Why all the fuss? (Editorial). Ann Intern Med 122:727, 1996
29. Yokoyama I, Ohtake T, Murakami T, Momomura S, Nishikawa J, Sasaki Y, Omata M: Reduced coronary flow reserve in familial hypercholesterolemia. J Nucl Med 37:1937-1942, 1996
30. Dayanikli F, Grambow D, Muzil O, Mosca L, Rubenfire M, Schwaiger M: Early detection of abnormal coronary flow reserve in asymptomatic men at high risk for coronary artery disease using positron emission tomography. Circulation 90:808-817, 1994
31. Yokoyama I, Ohtake T, Momomura S, Yonekura K, Kobayakawa N, Anyagi T, Sugiura S, Nishikawa J, Sasuti Y, Omata H: Altered myocardial vasodilation in patients with hypertriglyceridemia in anatomically normal coronary arteries. Arterioscler Thromb Vasc Biol. In press
32. Yokoyama I, Ohtake T, Momomura S, Nishikawa J, Sasaki Y, Omata M: Reduced coronary flow reserve in hypercholesterolemic patients without overt coronary stenosis. Circulation 94:3232-3238, 1996
33. Czernin J, Muller P, Chan S, Brunken RC, Porenta GP, Krivokapitch J, Chen K, Chan A, Phelps ME, Schelbert HR: Influence of age and hemodynamics on myocardial blood flow and flow reserve. Circulation 88:62-69, 1993
34. Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark AL Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest 87:2246-2252, 1991
35. Reaven GM, Lithell H, Landsberg L: Hypertension and associated metabolic abnormalities: the role of insulin resistance and the sympathoadrenal system. N Engl J Med 334:374-381, 1996
36. Zavaroni I, Mazza S, Dall' Aglio E, Gasparini P, Passeri M, Reaven GM: Prevalence of hyperinsulinemia in patients with high blood pressure. J Intern Med 231:235-240, 1902
37. Smith GT, Huang SC, Nienaber CA, Krivokapitch J, Schwaiger M, Schelbert HR: Noninvasive quantification of regional myocardial blood flow with N-13 ammonia and dynamic PET (Abstract). J Nucl Med 29:950, 1988
38. Sawada S, Muzik O, Beanlands RSB, Wolfe E, Hutchins GD, Schwaiger M: Interobserver and interstudy variability of myocardial blood flow-reserve measurement with nitrogen 13 ammonia-labeled positron emission tomography. J Nucl Cardiol 2:413-422, 1995
39. 13N-labeled ammonia and positron emission tomography. J Nucl Cardiol 3:494-507, 1996
40. Chan SY, Brunken RC, Czernin J, Porenta G, Kuhle W, Krivokapich J, Phelps ME, Schelbert HR: Comparison of maximal myocardial blood flow during adenosine infusion with that of intravenous dipyridamole in normal men. J Am Coll Cardiol 20:979-985, 1992
41. Krivokapitch J, Stevenson L, Kobashigawa J, Huang S, Schelbert HR: Quantification of absolute myocardial perfusion at rest and during exercise with positron emission tomography after human cardiac transplantation. J Am Coll Cardiol 18:512-517, 1991
42. Chan SY, Kobashigawa J, Stevenson LW: Myocardial blood flow at rest and during pharmacological vasodilation in cardiac transplant during and after successful treatment of rejection. Circulation 90:202-212, 1994
43. Di Carli M, Czernin J, Hoh CK, Gerbaudo VH, Brunken RC, Huang SC, Phelps ME, Schelbert HR: Relation among stenosis severity, myocardial blood flow, and flow reserve in patients with coronary artery disease. Circulation 91:1944-1951, 1995
44. Czernin J, Auerbach M, Sun KT, Phelps M, Schelbert HR: Effects of modified pharmacologic stress approaches on hyperemic myocardial blood flow. J Nucl Med 36:575-580, 1995
45. Bottcher M, Czernin J, Sun KT, Phelps ME, Schelbert HR: Effect of caffeine on myocardial blood flow at rest and during pharmacological vasodilation. J Nucl Med 36:2016-2021, 1995
46. Wu HM, Hoh CK, Buxton DB, Kuhle WG, Schelbert HR, Choi Y, Hawkins RA, Phelps ME, Huang SC: Quantification of myocardial blood flow using dynamic nitrogen-13-ammonia PET studies and factor analysis of dynamic structures. J Nucl Med 36:2087-2093, 1995
47. Nagamachi S, Czernin J, Kim AS, Sun KT, Bottcher M, Phelps ME, Schelbert HR: Reproducibility of measurements of regional resting and hyperemic myocardial blood flow assessed with PET. J Nucl Med 37:1621-1631, 1996
48. Hutchins GD, Schwaiger M, Rosenspire KC, Krivokapitch J, Schelbert HR, Kuhl DE: Noninvasive quantification of regional myocardial blood flow with N-13 ammonia and dynamic positron emission tomographic imaging. J Am Coll Cardiol 15:1032-1042, 1990